202 related articles for article (PubMed ID: 9712094)
1. Factors associated with active systemic lupus erythematosus after endstage renal disease.
Szeto CC; Li PK; Wong TY; Leung CB; Lui SF
J Rheumatol; 1998 Aug; 25(8):1520-5. PubMed ID: 9712094
[TBL] [Abstract][Full Text] [Related]
2. [Renal graft survival in patients with systemic lupus erythematosus].
Chew-Wong A; Soltero L; Diná E; Alvarez-Sandoval E; Alberú J; Gamba G; Correa-Rotter R
Rev Invest Clin; 2002; 54(1):21-8. PubMed ID: 11995403
[TBL] [Abstract][Full Text] [Related]
3. Extrarenal disease activity in systemic lupus erythematosus is not suppressed by chronic renal insufficiency or renal replacement therapy.
Bruce IN; Hallett DC; Gladman DD; Urowitz MB
J Rheumatol; 1999 Jul; 26(7):1490-4. PubMed ID: 10405935
[TBL] [Abstract][Full Text] [Related]
4. Ovarian failure and flares of systemic lupus erythematosus.
Mok CC; Wong RW; Lau CS
Arthritis Rheum; 1999 Jun; 42(6):1274-80. PubMed ID: 10366122
[TBL] [Abstract][Full Text] [Related]
5. Association of antinucleosome antibodies with disease flare in serologically active clinically quiescent patients with systemic lupus erythematosus.
Ng KP; Manson JJ; Rahman A; Isenberg DA
Arthritis Rheum; 2006 Dec; 55(6):900-4. PubMed ID: 17139667
[TBL] [Abstract][Full Text] [Related]
6. A comparison of the quality of life of patients with systemic lupus erythematosus with and without endstage renal disease.
Vu TV; Escalante A
J Rheumatol; 1999 Dec; 26(12):2595-601. PubMed ID: 10606368
[TBL] [Abstract][Full Text] [Related]
7. Clinical outcomes of systemic lupus erythematosus patients undergoing continuous ambulatory peritoneal dialysis.
Siu YP; Leung KT; Tong MK; Kwan TH; Mok CC
Nephrol Dial Transplant; 2005 Dec; 20(12):2797-802. PubMed ID: 16204302
[TBL] [Abstract][Full Text] [Related]
8. Treatment of end-stage renal disease due to lupus nephritis: comparison of six patients treated with both peritoneal and hemodialysis.
Stock GG; Krane NK
Adv Perit Dial; 1993; 9():147-51. PubMed ID: 8105910
[TBL] [Abstract][Full Text] [Related]
9. The impact of flare on disease costs of patients with systemic lupus erythematosus.
Zhu TY; Tam LS; Lee VW; Lee KK; Li EK
Arthritis Rheum; 2009 Sep; 61(9):1159-67. PubMed ID: 19714597
[TBL] [Abstract][Full Text] [Related]
10. Outcome in systemic lupus erythematosus: a prospective study of patients from a defined population.
Jonsson H; Nived O; Sturfelt G
Medicine (Baltimore); 1989 May; 68(3):141-50. PubMed ID: 2785628
[TBL] [Abstract][Full Text] [Related]
11. Predictors and outcome of renal flares after successful cyclophosphamide treatment for diffuse proliferative lupus glomerulonephritis.
Mok CC; Ying KY; Tang S; Leung CY; Lee KW; Ng WL; Wong RW; Lau CS
Arthritis Rheum; 2004 Aug; 50(8):2559-68. PubMed ID: 15334470
[TBL] [Abstract][Full Text] [Related]
12. Effect of severe neuropsychiatric manifestations on short-term damage in systemic lupus erythematosus.
Fragoso-Loyo HE; Sánchez-Guerrero J
J Rheumatol; 2007 Jan; 34(1):76-80. PubMed ID: 17143970
[TBL] [Abstract][Full Text] [Related]
13. Climatic influence on the prevalence of noncutaneous disease flare in systemic lupus erythematosus in Hong Kong.
Szeto CC; Mok HY; Chow KM; Lee TC; Leung JY; Li EK; Tsui TK; Yu S; Tam LS
J Rheumatol; 2008 Jun; 35(6):1031-7. PubMed ID: 18398942
[TBL] [Abstract][Full Text] [Related]
14. The effect of menopause on disease activity in systemic lupus erythematosus.
Urowitz MB; Ibañez D; Jerome D; Gladman DD
J Rheumatol; 2006 Nov; 33(11):2192-8. PubMed ID: 16981295
[TBL] [Abstract][Full Text] [Related]
15. End-stage renal failure in systemic lupus erythematosus with nephritis.
Correia P; Cameron JS; Ogg CS; Williams DG; Bewick M; Hicks JA
Clin Nephrol; 1984 Dec; 22(6):293-302. PubMed ID: 6396007
[TBL] [Abstract][Full Text] [Related]
16. Outcome of renal transplantation in patients with systemic lupus erythematosus.
Deegens JK; Artz MA; Hoitsma AJ; Wetzels JF
Transpl Int; 2003 Jun; 16(6):411-8. PubMed ID: 12819872
[TBL] [Abstract][Full Text] [Related]
17. Peritoneal dialysis and hemodialysis in systemic lupus erythematosus patients: comparison of clinical outcomes.
Weng CH; Hsu CW; Yu CC; Yen TH; Yang CW; Hung CC
Kidney Blood Press Res; 2009; 32(6):451-6. PubMed ID: 20016213
[TBL] [Abstract][Full Text] [Related]
18. Anti-C1q antibodies in nephritis: correlation between titres and renal disease activity and positive predictive value in systemic lupus erythematosus.
Marto N; Bertolaccini ML; Calabuig E; Hughes GR; Khamashta MA
Ann Rheum Dis; 2005 Mar; 64(3):444-8. PubMed ID: 15286009
[TBL] [Abstract][Full Text] [Related]
19. Flares in pediatric systemic lupus erythematosus.
Weiss JE; Sison CP; Ilowite NT; Gottlieb BS; Eberhard BA
J Rheumatol; 2007 Jun; 34(6):1341-4. PubMed ID: 17477466
[TBL] [Abstract][Full Text] [Related]
20. Thrombotic microangiopathy in United States long-term dialysis patients.
Perkins RM; Reynolds JC; Ahuja TS; Reid T; Agodoa LY; Bohen EM; Yuan CM; Abbott KC
Nephrol Dial Transplant; 2006 Jan; 21(1):191-6. PubMed ID: 16204286
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
